Living with HIV is very different today from previous decades. Effective antiretroviral therapy (ART) can suppress HIV and help most people live long, healthy lives. However, some people living with HIV can still experience symptoms such as chronic pain, neuropathic pain, nausea, appetite changes, fatigue or other health problems.
This has led to interest in medical cannabis for HIV symptoms, particularly where conventional approaches have not provided sufficient relief.
However, it is important to distinguish symptom management from HIV treatment. Medical cannabis does not cure HIV and should not replace antiretroviral therapy. In the UK, cannabis-based medicines are prescribed by specialist doctors in specific clinical circumstances, and the evidence for pain and HIV-related symptoms remains limited.
This guide explains what the research says, which HIV-related symptoms have been studied, potential risks, drug interactions, and how medicinal cannabis prescribing works in the UK.
Can Medical Cannabis Help With HIV Symptoms?
There is research suggesting that cannabinoids may help with some symptoms experienced by people living with HIV, particularly pain, nausea and appetite-related problems.
However, the evidence is not strong enough to conclude that medical cannabis is an effective treatment for HIV itself.
A systematic review of pharmacological and non-pharmacological treatments for chronic pain in people with HIV found that the available studies were generally low or very low quality. Some controlled studies of cannabis reported positive results, but follow-up was short, highlighting the need for further research.
A broader evidence-mapping review also found research into cannabis and HIV-related symptoms, but concluded that the evidence across medical uses was heterogeneous and that conclusions were weak for many comparisons.
What Does This Mean for Patients?
The evidence does not mean that cannabis should automatically be used for HIV symptoms.
Instead, it suggests that cannabinoids may have a role in symptom management for selected patients, subject to:
-
The specific symptom being treated
-
Previous treatments
-
Other medicines being taken
-
Potential drug interactions
-
Medical history
-
Potential adverse effects
-
The clinician’s assessment of benefits and risks
Which HIV Symptoms Have Been Studied?
Research has examined cannabis and cannabinoids in relation to several symptoms reported by people living with HIV.
HIV-Related Pain
Pain is one of the most studied potential uses.
People living with HIV can experience different types of pain, including neuropathic pain, which may involve burning, tingling, numbness or electric-shock-like sensations.
A randomised placebo-controlled trial has investigated smoked cannabis for painful HIV-associated sensory neuropathy, and systematic reviews have identified cannabis among interventions studied for HIV-associated chronic pain. However, the evidence base remains limited and older studies do not establish that cannabis is suitable for everyone.
NHS England currently states that evidence for cannabis-based medicines in pain is not sufficiently developed and that there are no licensed cannabis-based products specifically available for pain.
Nausea
Nausea has also been investigated in people living with HIV.
An older observational study reported that people using cannabis for HIV symptoms commonly reported improvements in nausea and other symptoms. However, self-reported improvement does not establish that cannabis caused the benefit.
Cannabinoid medicines have stronger evidence for certain forms of chemotherapy-related nausea and vomiting, but that evidence should not automatically be applied to HIV-related nausea. NICE specifically addresses cannabis-based medicines for particular indications rather than recommending them broadly for chronic symptoms.
Appetite and Weight Loss
Loss of appetite has historically been an important reason for studying cannabis and cannabinoids in HIV.
An older study of people living with HIV reported substantial self-reported improvement in appetite among cannabis users.
A systematic review of cannabinoids also found low-quality evidence suggesting an association with weight gain in HIV infection.
However, modern HIV treatment has changed the clinical landscape considerably. Loss of appetite or unexplained weight loss should be investigated medically rather than assumed to be a symptom that requires cannabis.
Does Medical Cannabis Treat HIV?
No.
Medical cannabis should not be considered an antiviral treatment for HIV.
HIV is treated with antiretroviral medicines, which reduce the amount of HIV in the blood and help prevent immune-system damage. The NHS states that there is currently no cure for HIV, but effective treatment allows most people with HIV to live long and healthy lives.
Cannabis-based medicines, where prescribed, would be considered for an appropriate symptom or clinical indication, not as a replacement for ART.
This distinction is particularly important because stopping or changing HIV medication without medical advice can have serious consequences.
Medical Cannabis for HIV-Related Neuropathic Pain
Neuropathic pain can be particularly difficult to manage.
It may feel like:
-
Burning
-
Pins and needles
-
Electric shocks
-
Tingling
-
Numbness
-
Increased sensitivity to touch
-
Shooting or stabbing pain
HIV-associated neuropathy has been studied in clinical research involving cannabis, including a randomised controlled trial. A systematic review found some positive controlled-study results but noted that the evidence was limited by short follow-up and generally low-quality studies.
Current NICE guidance does not recommend cannabis-based medicines as routine treatment for neuropathic pain in non-specialist settings. Cannabis sativa extract is among treatments that should not be started in non-specialist settings unless advised by a specialist.
This makes specialist assessment particularly important when someone with HIV is considering medicinal cannabis for nerve pain.
What Are the Potential Benefits of Medical Cannabis for HIV Symptoms?
Depending on the individual and the indication, potential benefits investigated in research include:
-
Reduction in certain types of pain
-
Possible improvement in nausea
-
Possible improvement in appetite
-
Potential symptom relief when other treatments have not been sufficient
But these potential benefits need to be balanced against the limitations of the evidence.
A 2024 scoping review of observational research into cannabis for symptom management among people with HIV and cancer found that much of the research was observational and that there were important gaps in evidence concerning effectiveness, safety, dosing and delivery methods.
Potential benefit should therefore be assessed individually rather than assumed from cannabis use alone.
What Are the Risks of Medical Cannabis?
Cannabis-based medicines can cause side effects, particularly products containing THC.
Possible effects include:
-
Dizziness
-
Drowsiness
-
Fatigue
-
Nausea
-
Changes in appetite
-
Mood or behavioural changes
-
Feeling intoxicated
-
Confusion
-
Hallucinations in some circumstances
The NHS also notes potential risks associated with THC-containing products, including dependence and psychosis-related risks in some people.
The likelihood and severity of side effects can depend on the product, cannabinoid content, dose, individual circumstances and other medicines.
Can Medical Cannabis Interact With HIV Medication?
Yes, potential medicine interactions need to be considered.
This is especially important for people living with HIV because many patients take antiretroviral medicines or other long-term medicines.
CBD and THC are metabolised through several of the same enzyme systems involved in processing prescription medicines. A systematic review of cannabinoid drug interactions identified potential interactions involving enzymes including CYP3A4, CYP2C9 and CYP2C19.
The NHS advises people taking medical cannabis to discuss possible interactions with a specialist because CBD and THC can affect how other medicines work.
Never Stop HIV Medication to Use Cannabis
Medical cannabis should be considered alongside appropriate HIV care, not instead of it.
If you take antiretroviral medication, tell the prescribing clinician about every medicine, supplement and cannabis-based product you use.
Your HIV specialist and medicinal-cannabis clinician may need to consider:
-
Your current ART regimen
-
Other prescription medicines
-
Liver function
-
Other medical conditions
-
Cannabis product composition
-
Potential interactions
-
Previous adverse reactions
Is Medical Cannabis Legal in the UK?
Cannabis-based products for medicinal use can legally be prescribed in the UK under controlled circumstances.
Since November 2018, specialist doctors on the GMC Specialist Register have been legally able to prescribe cannabis-based medicinal products where clinically appropriate.
However, this does not mean that anyone with HIV can automatically obtain a medical cannabis prescription.
NHS England states that cannabis-based medicines are generally not first-line treatments and that prescribing decisions need to consider the clinical evidence, other medicines, patient preferences, and suitability of licensed alternatives.
Can You Get Medical Cannabis for HIV in the UK?
Potentially, but eligibility is determined on an individual clinical basis.
There is no simple rule that says an HIV diagnosis automatically qualifies someone for medical cannabis.
A specialist may consider factors such as:
-
The symptom being treated
-
Severity and duration of symptoms
-
Previous treatments
-
Response to conventional medicines
-
Side effects from existing treatments
-
Other medical conditions
-
Current HIV medication
-
Potential interactions
-
Available evidence
-
Overall risk-benefit assessment
Private specialist prescribing is legally possible in the UK, but the same principle applies: the clinician must determine that prescribing is clinically appropriate. NHS England confirms that private doctors on the GMC Specialist Register can prescribe cannabis-based products for medicinal use.
What Happens During a Medical Cannabis Assessment?
A specialist assessment will generally involve reviewing your medical history and current treatment.
You may be asked about:
Your HIV Treatment
The clinician may need information about:
-
Your current antiretroviral medicines
-
Viral load
-
Other prescribed medicines
-
Previous treatment changes
-
Relevant medical history
Your Symptoms
Be prepared to explain:
-
What symptom you want help with
-
When it started
-
How severe it is
-
How it affects daily life
-
What makes it better or worse
-
Whether it affects sleep or activity
Previous Treatments
Your clinician may want to know:
-
Which treatments you have tried
-
Whether they helped
-
What side effects occurred
-
Why a treatment was stopped
The goal is to determine whether a cannabis-based medicine is appropriate for the individual clinical problem, rather than simply whether cannabis is something the patient is interested in trying.
What Does the Research Say About Cannabis and HIV?
The research is mixed and should be interpreted carefully.
An older observational study of 523 HIV-positive patients found that 27% reported using cannabis for symptom management. Among users, high proportions reported improvements in appetite, muscle pain, nausea and nerve pain. However, the study was based on patient reports rather than a randomised comparison, so it cannot establish that cannabis caused those improvements.
More recent observational research has also highlighted the complexity of cannabis use among people living with HIV. A 2025 study involving 1,226 people with HIV found that recent cannabis use was associated with a greater prevalence of several bothersome symptoms, including memory problems, depression, anxiety and nausea. The authors noted that the findings raise concerns and do not establish causation.
This is why “cannabis helps HIV symptoms” is too broad a conclusion.
The more accurate position is that cannabinoids have been investigated for specific symptoms, but evidence quality varies considerably and individual assessment is important.
Medical Cannabis vs Recreational Cannabis for HIV Symptoms
These should not be treated as the same thing.
Medical Cannabis
A prescribed cannabis-based medicine is selected and monitored within a medical framework.
Recreational or Unregulated Cannabis
Products obtained outside the medical system can have uncertain:
-
Strength
-
Cannabinoid content
-
Purity
-
Contaminants
-
Dosage
The NHS warns that cannabis products bought online may be illegal or potentially dangerous, and that the quality and content of many products cannot be guaranteed.
For someone taking HIV medication, using an unregulated product can make assessment of dose, interactions and adverse effects particularly difficult.
Is CBD Oil the Same as Medical Cannabis?
No.
“Medical cannabis” refers broadly to cannabis-based medicines used therapeutically, while commercially available CBD or hemp products are not automatically equivalent to prescribed medicinal products.
NHS guidance notes that some CBD products are sold legally as food supplements, but their quality and health effects are not guaranteed.
NHS England also distinguishes regulated cannabis-based medicinal products from raw or unrefined cannabis and cannabis/hemp oil products sold online or in health-food shops.
How to Discuss Medical Cannabis With Your HIV Doctor
If you are considering medical cannabis, prepare a short record of your symptoms and treatment history.
Bring:
-
Your current medication list
-
Your HIV treatment details
-
A description of your symptoms
-
Previous treatments tried
-
Side effects experienced
-
Relevant medical conditions
-
Questions about potential interactions
Useful questions include:
-
Could any of my current medicines be causing or worsening this symptom?
-
Are there licensed treatments I should try first?
-
Could a cannabis-based medicine interact with my HIV medication?
-
What evidence exists for cannabis for my specific symptom?
-
What side effects should I watch for?
-
How would treatment effectiveness be monitored?
This creates a more informed discussion than simply asking whether cannabis is “good for HIV.”
Frequently Asked Questions
Can medical cannabis cure HIV?
No. Medical cannabis is not a cure for HIV and should not replace antiretroviral therapy. HIV is treated with antiretroviral medicines that suppress the virus.
Can medical cannabis help HIV nerve pain?
Cannabis has been studied for painful HIV-associated neuropathy, including in randomised research. However, the evidence remains limited, and NICE does not recommend cannabis-based medicines as routine treatment for neuropathic pain in non-specialist settings.
Can cannabis improve appetite in people with HIV?
Appetite improvement has been reported in studies of cannabis use among people with HIV, and cannabinoids have been studied for HIV-associated weight loss. However, the evidence is limited and appetite or unexplained weight loss should be medically assessed.
Can I take CBD while taking HIV medication?
Do not assume that CBD is automatically safe with your HIV medication. Cannabinoids can interact with drug-metabolising enzymes, and the NHS recommends discussing possible interactions with a specialist.
Can my GP prescribe medical cannabis for HIV symptoms?
Cannabis-based medicinal products are subject to specialist prescribing requirements in the UK. NHS England states that prescribing responsibility rests with a clinician on the GMC Specialist Register, although arrangements for ongoing prescribing can vary.
Is medical cannabis available on the NHS for HIV?
There is no general NHS recommendation that people with HIV should receive medical cannabis. Prescribing of cannabis-based medicines is limited and depends on individual clinical circumstances, the evidence for the indication and the suitability of other treatments.
Is smoking cannabis a medical cannabis treatment?
No. UK regulations specifically prohibit smoking cannabis and cannabis-based products for medicinal use. Prescribed cannabis-based medicines are supplied in appropriate pharmaceutical forms rather than as smoked cannabis.
Final Thoughts
Medical cannabis for HIV symptoms is an area of ongoing research rather than a replacement for established HIV treatment.
There is evidence that cannabinoids have been studied for symptoms including neuropathic pain, nausea and appetite problems, but the quality and relevance of that evidence varies. Current UK guidance is cautious, particularly around chronic pain, and emphasises specialist prescribing, consideration of alternative treatments and careful assessment of potential risks and interactions.
For anyone living with HIV, the priority remains effective antiretroviral therapy and specialist HIV care. If symptoms remain difficult to manage, medical cannabis may be something to discuss with an appropriately qualified clinician as one potential option—not as a treatment for HIV itself.
For patients considering this route, Emerald Health Clinic provides information about its approach to medical cannabis and HIV-related symptoms. Any decision about treatment should be based on an individual clinical assessment.
